Jason Flowerday

Jason is the CEO of VoxNeuro. As CEO, Jason leads the planning and execution of VoxNeuro’s short and long-term business strategies while managing its allocation of capital and entry into new markets. Jason serves VoxNeuro’s stakeholders, including its Board of Directors and investors, and leads the team in its effort to become The Brain Company.

Jason brings over 25 years of industry-relevant, executive leadership experience to VoxNeuro. His success in the life sciences and health technology sectors began with pharmaceutical leaders, Bayer and Johnson & Johnson, followed by CEO roles across specialty pharma, medical device, diagnostics and health tech companies. During his time building and leading these companies, Jason was successful in the pursuit of new markets, investment capital, revenue growth and multiple liquidity events.